Hepion Pharmaceuticals Statistics
Total Valuation
HEPA has a market cap or net worth of $5.92 million. The enterprise value is -$7.02 million.
| Market Cap | 5.92M |
| Enterprise Value | -7.02M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HEPA has 5.80 million shares outstanding. The number of shares has increased by 33.09% in one year.
| Shares Outstanding | 5.80M |
| Shares Change (YoY) | +33.09% |
| Shares Change (QoQ) | +15.11% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 12.28% |
| Float | 5.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.79 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.00, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.00 |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,644.86 |
Financial Efficiency
Return on equity (ROE) is -268.70% and return on invested capital (ROIC) is -525.17%.
| Return on Equity (ROE) | -268.70% |
| Return on Assets (ROA) | -161.20% |
| Return on Capital (ROIC) | -525.17% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.75M |
| Employee Count | 22 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.38M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.55% in the last 52 weeks. The beta is 1.86, so HEPA's price volatility has been higher than the market average.
| Beta (5Y) | 1.86 |
| 52-Week Price Change | -89.55% |
| 50-Day Moving Average | 1.13 |
| 200-Day Moving Average | 2.41 |
| Relative Strength Index (RSI) | 43.03 |
| Average Volume (20 Days) | 18,486 |
Short Selling Information
The latest short interest is 24,421, so 0.42% of the outstanding shares have been sold short.
| Short Interest | 24,421 |
| Short Previous Month | 15,437 |
| Short % of Shares Out | 0.42% |
| Short % of Float | 0.48% |
| Short Ratio (days to cover) | 0.99 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -40.42M |
| Pretax Income | -41.90M |
| Net Income | -38.52M |
| EBITDA | -41.81M |
| EBIT | -41.89M |
| Earnings Per Share (EPS) | -$9.40 |
Balance Sheet
The company has $13.11 million in cash and $175,268 in debt, giving a net cash position of $12.93 million or $2.23 per share.
| Cash & Cash Equivalents | 13.11M |
| Total Debt | 175,268 |
| Net Cash | 12.93M |
| Net Cash Per Share | $2.23 |
| Equity (Book Value) | 7.52M |
| Book Value Per Share | 1.30 |
| Working Capital | 12.86M |
Cash Flow
In the last 12 months, operating cash flow was -$36.29 million and capital expenditures -$14,304, giving a free cash flow of -$36.31 million.
| Operating Cash Flow | -36.29M |
| Capital Expenditures | -14,304 |
| Free Cash Flow | -36.31M |
| FCF Per Share | -$7.16 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -33.09% |
| Shareholder Yield | -33.09% |
| Earnings Yield | -651.21% |
| FCF Yield | -613.77% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 11, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | May 11, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |